News-Medical.Net on MSN
NCCN publishes new guidelines for management of pediatric soft tissue sarcomas
The National Comprehensive Cancer Network ® (NCCN ® ) today published new NCCN Clinical Practice Guidelines in Oncology (NCCN ...
LP-284 targets DNA repair defects in cancers, showing promise in preclinical and early clinical trials across multiple cancer types. The FDA's orphan drug designation supports LP-284's development for ...
Updated NCCN pediatric STS guidelines emphasize risk stratification, imaging, multimodal therapy, and clinical trial enrollment to improve outcomes. The National Comprehensive Cancer Network (NCCN) ...
The Journal of Clinical Oncology podcast, hosted by Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology.
Iovance Biotherapeutics shares rose after the company shared positive trial results from a treatment designed for soft tissue cancer. The stock gained 26% to $3.65 Tuesday. Shares are still down 32% ...
Objective Response Rate (ORR) in Advanced Sarcomas Significant Market Opportunity with More than 8,000 Patients Diagnosed Annually in the U.S. and Europe SAN CARLOS, Calif., Feb. 24, 2026 (GLOBE ...
An Era of Advances in Systemic Therapies for Advanced Thyroid Cancer Soft tissue sarcomas (STS) of the extremity and trunk are heterogeneous and rare tumors that require coordinated multidisciplinary ...
The Express Tribune on MSN
Rise in bone, soft tissue tumours reported
Doctors in Karachi have reported a growing number of musculoskeletal tumour cases, with specialists urging early diagnosis to prevent life-threatening complications.Speaking to The Express Tribune, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results